Canada markets close in 40 minutes

CVS Health Corporation (CVS)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
87.83-10.75 (-10.90%)
As of 03:20PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 129.42B
Enterprise Value 188.60B
Trailing P/E 16.06
Forward P/E 10.93
PEG Ratio (5 yr expected) 1.33
Price/Sales (ttm)0.43
Price/Book (mrq)1.72
Enterprise Value/Revenue 0.61
Enterprise Value/EBITDA 10.80

Trading Information

Stock Price History

Beta (5Y Monthly) 0.71
52-Week Change 316.84%
S&P500 52-Week Change 3-14.73%
52 Week High 3111.25
52 Week Low 382.20
50-Day Moving Average 3100.69
200-Day Moving Average 3100.58

Share Statistics

Avg Vol (3 month) 34.71M
Avg Vol (10 day) 34.61M
Shares Outstanding 51.31B
Implied Shares Outstanding 6N/A
Float 81.31B
% Held by Insiders 10.38%
% Held by Institutions 179.96%
Shares Short (Sept 14, 2022) 414.38M
Short Ratio (Sept 14, 2022) 43.23
Short % of Float (Sept 14, 2022) 41.10%
Short % of Shares Outstanding (Sept 14, 2022) 41.10%
Shares Short (prior month Aug 14, 2022) 415.04M

Dividends & Splits

Forward Annual Dividend Rate 42.2
Forward Annual Dividend Yield 42.19%
Trailing Annual Dividend Rate 32.10
Trailing Annual Dividend Yield 32.13%
5 Year Average Dividend Yield 42.82
Payout Ratio 434.20%
Dividend Date 3Oct 31, 2022
Ex-Dividend Date 4Oct 19, 2022
Last Split Factor 22:1
Last Split Date 3Jun 06, 2005

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022


Profit Margin 2.66%
Operating Margin (ttm)4.71%

Management Effectiveness

Return on Assets (ttm)3.91%
Return on Equity (ttm)10.94%

Income Statement

Revenue (ttm)306.93B
Revenue Per Share (ttm)233.05
Quarterly Revenue Growth (yoy)11.30%
Gross Profit (ttm)50.85B
Net Income Avi to Common (ttm)8.17B
Diluted EPS (ttm)6.14
Quarterly Earnings Growth (yoy)6.00%

Balance Sheet

Total Cash (mrq)14.99B
Total Cash Per Share (mrq)11.42
Total Debt (mrq)74.17B
Total Debt/Equity (mrq)98.23
Current Ratio (mrq)0.91
Book Value Per Share (mrq)57.31

Cash Flow Statement

Operating Cash Flow (ttm)18.53B
Levered Free Cash Flow (ttm)14.16B